- Netflix: The Biggest Empty Promise Since Enron?
- Why Car Prices Vary From City To City
- Big Bank Phobia: Not Too Big to Fail
- Apple Should Still Fire Tim Cook
- Expect Your Health Care in Retirement to Hit $200,000
Article
GenVec's CEO Discusses Q2 2012 Results - Earnings Call Transcript
GenVec's CEO Discusses Q2 2012 Results - Earnings Call Transcript
03:17PM 08/09/12
Article
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Maryland on behalf of investors who purchased GenVec, Inc.
02:46PM 04/03/12
Article
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Maryland on behalf of investors who purchased GenVec, Inc.
04:36PM 02/08/12
Article
Law Firm Brower Piven Announces Investigation Of Investor Securities Fraud Against GenVec, Inc.
The law firm of Brower Piven, A Professional Corporation, is investigating potential securities fraud claims against GenVec, Inc.
03:52PM 01/10/12
Article
GenVec Expands Collaboration With Merial
Merial to Explore Applications of GenVec Technology for Animal Health
07:44AM 05/03/11
Article
GenVec Value Slammed on Drug Failure
The blowup of GenVec's drug for pancreatic cancer in a phase III study reduces fair value to around 30 cents a share.
06:42PM 03/30/10
Article
GenVec, Encorium Group: Early Volume Plays
Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.
10:10AM 03/30/10
Video
Stock Wrap: The Real Story, March 12
Stocks are hugging the flat line Friday after March consumer sentiment dipped, though February retail sales data came in ahead of estimates.
04:42PM 03/12/10
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
